ApprovalTrail

Approval · Notice of Compliance 810 · 2002

TRANEXAMIC ACID: Notice of Compliance 810

Issued October 4, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
810
Date
October 4, 2002
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Antifibrinolytic agent
Canadian reference product
CYKLOKAPRON (Pharmacia And Upjohn Company)

Products in this notice

BrandDINStatus today
TRANEXAMIC ACID02246365Marketed

Medicinal ingredients